• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓冲剂在蛋白质制剂中的作用。

Role of Buffers in Protein Formulations.

作者信息

Zbacnik Teddy J, Holcomb Ryan E, Katayama Derrick S, Murphy Brian M, Payne Robert W, Coccaro Richard C, Evans Gabriel J, Matsuura James E, Henry Charles S, Manning Mark Cornell

机构信息

LegacyBioDesign LLC, Johnstown, Colorado 80534.

LegacyBioDesign LLC, Johnstown, Colorado 80534; Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523.

出版信息

J Pharm Sci. 2017 Mar;106(3):713-733. doi: 10.1016/j.xphs.2016.11.014. Epub 2016 Nov 26.

DOI:10.1016/j.xphs.2016.11.014
PMID:27894967
Abstract

Buffers comprise an integral component of protein formulations. Not only do they function to regulate shifts in pH, they also can stabilize proteins by a variety of mechanisms. The ability of buffers to stabilize therapeutic proteins whether in liquid formulations, frozen solutions, or the solid state is highlighted in this review. Addition of buffers can result in increased conformational stability of proteins, whether by ligand binding or by an excluded solute mechanism. In addition, they can alter the colloidal stability of proteins and modulate interfacial damage. Buffers can also lead to destabilization of proteins, and the stability of buffers themselves is presented. Furthermore, the potential safety and toxicity issues of buffers are discussed, with a special emphasis on the influence of buffers on the perceived pain upon injection. Finally, the interaction of buffers with other excipients is examined.

摘要

缓冲剂是蛋白质制剂不可或缺的组成部分。它们不仅能调节pH值的变化,还能通过多种机制稳定蛋白质。本综述重点介绍了缓冲剂在液态制剂、冷冻溶液或固态中稳定治疗性蛋白质的能力。缓冲剂的添加可提高蛋白质的构象稳定性,无论是通过配体结合还是通过排除溶质机制。此外,它们可以改变蛋白质的胶体稳定性并调节界面损伤。缓冲剂也可能导致蛋白质不稳定,并介绍了缓冲剂本身的稳定性。此外,还讨论了缓冲剂潜在的安全性和毒性问题,特别强调了缓冲剂对注射时痛感的影响。最后,研究了缓冲剂与其他辅料的相互作用。

相似文献

1
Role of Buffers in Protein Formulations.缓冲剂在蛋白质制剂中的作用。
J Pharm Sci. 2017 Mar;106(3):713-733. doi: 10.1016/j.xphs.2016.11.014. Epub 2016 Nov 26.
2
Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.无缓冲剂冻干制剂的稳定性:高蛋白浓度下单克隆抗体的可行性研究
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):125-39. doi: 10.1016/j.ejpb.2015.09.017. Epub 2015 Oct 9.
3
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability.生物制药制剂中的替代缓冲液系统及其对蛋白质稳定性的影响。
Acta Pharm. 2024 Sep 14;74(3):479-493. doi: 10.2478/acph-2024-0022. Print 2024 Sep 1.
4
Preformulation Characterization, Stabilization, and Formulation Design for the Acrylodan-Labeled Glucose-Binding Protein SM4-AC.丙烯罗丹明标记的葡萄糖结合蛋白SM4-AC的处方前表征、稳定化及制剂设计
J Pharm Sci. 2017 May;106(5):1197-1210. doi: 10.1016/j.xphs.2017.01.004. Epub 2017 Jan 11.
5
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
6
Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.近年来药物制剂中稳定肽和蛋白质的趋势-辅料选择中的考虑因素。
Expert Opin Drug Deliv. 2009 Nov;6(11):1219-30. doi: 10.1517/17425240903199143.
7
Stabilization of therapeutic proteins by chemical and physical methods.通过化学和物理方法稳定治疗性蛋白质。
Methods Mol Biol. 2005;308:287-92. doi: 10.1385/1-59259-922-2:287.
8
Development of new ophthalmic suspension prednisolone acetate 1%.新型1%醋酸泼尼松龙眼用混悬液的研制
Pak J Pharm Sci. 2010 Apr;23(2):149-54.
9
Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities.高浓度内皮抑素制剂的优化:辅料对胶体稳定性和构象稳定性贡献的协调
Int J Pharm. 2017 Sep 15;530(1-2):173-186. doi: 10.1016/j.ijpharm.2017.07.057. Epub 2017 Jul 26.
10
Solid-state surface acidity and pH-stability profiles of amorphous quinapril hydrochloride and silicate formulations.无定形盐酸喹那普利和硅酸盐制剂的固态表面酸度和 pH 稳定性分布。
J Pharm Sci. 2010 Jun;99(6):2786-99. doi: 10.1002/jps.22051.

引用本文的文献

1
Stabilising large biologics through complimentary buffer component protection and rapid drying times.通过互补缓冲成分保护和快速干燥时间来稳定大型生物制品。
Int J Pharm X. 2025 Aug 12;10:100374. doi: 10.1016/j.ijpx.2025.100374. eCollection 2025 Dec.
2
A Review on the Stability Challenges of Advanced Biologic Therapeutics.先进生物治疗药物稳定性挑战综述
Pharmaceutics. 2025 Apr 23;17(5):550. doi: 10.3390/pharmaceutics17050550.
3
Optimizing experimental conditions: the role of buffered environments in microbial isolation, physiological studies, and taxonomic characterization.
优化实验条件:缓冲环境在微生物分离、生理学研究和分类学表征中的作用。
Appl Environ Microbiol. 2025 Jun 18;91(6):e0172824. doi: 10.1128/aem.01728-24. Epub 2025 May 14.
4
Buffer 4-Ethylmorpholinium/Acetate: Exploring a New Alternative Buffer for Native Mass Spectrometry.缓冲液4-乙基吗啉/乙酸盐:探索用于原生质谱分析的新型替代缓冲液。
Rapid Commun Mass Spectrom. 2025 Jul 30;39(14):e10048. doi: 10.1002/rcm.10048.
5
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies.高通量技术驱动高浓度蛋白质制剂的快速发展
Pharm Res. 2025 Jan;42(1):151-171. doi: 10.1007/s11095-024-03801-3. Epub 2025 Jan 17.
6
Monitoring the Dilution of Buffer Solutions with Different pH Values above and below Physiological pH in Very Small Volumes.监测非常小体积中生理 pH 值以上和以下的不同 pH 值缓冲溶液的稀释情况。
Sensors (Basel). 2024 Sep 4;24(17):5751. doi: 10.3390/s24175751.
7
Oxidative modulations in platelets stored in SSP+, PAS-G and Tyrode's buffer: a comparative analysis.在SSP +、PAS - G和台氏缓冲液中储存的血小板的氧化调节:一项比较分析。
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S80-S89. doi: 10.1016/j.htct.2024.04.121. Epub 2024 Aug 18.
8
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
9
Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods.基于 HPLC 分离和生物物理方法鉴定表面活性剂对单克隆抗体特性的影响。
Pharm Res. 2024 Apr;41(4):779-793. doi: 10.1007/s11095-024-03684-4. Epub 2024 Mar 22.
10
Do Ionic Liquids Exhibit the Required Characteristics to Dissolve, Extract, Stabilize, and Purify Proteins? Past-Present-Future Assessment.离子液体是否具有溶解、提取、稳定和纯化蛋白质所需的特性?过去-现在-未来评估。
Chem Rev. 2024 Mar 27;124(6):3037-3084. doi: 10.1021/acs.chemrev.3c00551. Epub 2024 Mar 4.